Priority Date: 25.05.16 (GB 20160009193)

NOVEL PEPTIDES, COMBINATION OF PEPTIDES AS TARGETS AND FOR USE IN IMMUNOTHERAPY AGAINST GALLBLADDER CANCER AND CHOLANGIOCARCINOMA AND OTHER CANCERS

  • Application ID: EP17727147
  • Status: Request for examination was made

Applicant

Technology company logo small
Technology Company

Attorney

operating since 1930
Headquarter in Bremen and 13 offices
active in Legal Services and IP Consulting

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 179 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 25.05.2016 - Priority Date (GB 20160009193)
  • 30.11.2017 - Publication A1 (WO2017202806)
  • 10.04.2019 - Publication A1 (EP3463425)

IPC Classification